Published in J Vasc Access on January 10, 2011
Advanced Ultrasound Applications for Predicting AVF Outcomes (AUAPAVFO) | NCT04141358
Current tools for prediction of arteriovenous fistula outcomes. Clin Kidney J (2015) 0.94
Incomplete restoration of homeostatic shear stress within arteriovenous fistulae. J Biomech Eng (2013) 0.89
Novel paradigms for dialysis vascular access: downstream vascular biology--is there a final common pathway? Clin J Am Soc Nephrol (2013) 0.89
Pre-existing and Postoperative Intimal Hyperplasia and Arteriovenous Fistula Outcomes. Am J Kidney Dis (2016) 0.82
Comparative analysis of cellular phenotypes within the neointima from vein segments collected prior to vascular access surgery and stenotic arteriovenous dialysis accesses. Semin Dial (2013) 0.81
Effects of wall distensibility in hemodynamic simulations of an arteriovenous fistula. Biomech Model Mechanobiol (2013) 0.78
Role of vascular function in predicting arteriovenous fistula outcomes: an observational pilot study. Can J Kidney Health Dis (2015) 0.76
Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol (2002) 16.25
Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol (1995) 5.26
Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation (1995) 4.59
Why don't fistulas mature? Kidney Int (2006) 2.89
Total nitric oxide production is low in patients with chronic renal disease. Kidney Int (2000) 2.11
Flow-induced vasodilation of the human brachial artery is impaired in patients <40 years of age with coronary artery disease. Am J Cardiol (1996) 2.09
Shear stress regulation of artery lumen diameter in experimental atherogenesis. J Vasc Surg (1987) 1.53
Abnormalities of endothelial function in patients with predialysis renal failure. Heart (2000) 1.43
Nitric oxide production is reduced in patients with chronic renal failure. Arterioscler Thromb Vasc Biol (1999) 1.36
Low-pressure environment and remodelling of the forearm vein in Brescia-Cimino haemodialysis access. Nephrol Dial Transplant (2002) 1.29
Impaired endothelium-dependent vasodilatation in renal failure in humans. Nephrol Dial Transplant (2001) 1.11
Atorvastatin restores endothelial function in normocholesterolemic smokers independent of changes in low-density lipoprotein. Circ Res (2004) 1.05
Flow-induced arterial remodeling relates to endothelial function in the human forearm. Circulation (2008) 1.03
Endothelium-dependent vasodilatation and distensibility of large arteries in chronic haemodialysis patients. Nephrol Dial Transplant (1997) 0.99
The effect of flow changes on the arterial system proximal to an arteriovenous fistula for hemodialysis. Ultrasound Med Biol (2005) 0.99
Impaired endothelium-dependent vasodilatation in uraemia. Nephrol Dial Transplant (2000) 0.94
Investigations into the relationship between hemodynamics and vascular alterations in an established arteriovenous fistula. Med Eng Phys (2006) 0.91
Altered flow-dependent vasodilatation of conduit arteries in maintenance haemodialysis. Nephrol Dial Transplant (1997) 0.91
A prospective study of end-to-side vs. side-to-side arteriovenous fistulas for haemodialysis. Br J Surg (1984) 0.89
High-resolution quantitative imaging of mammalian and bacterial cells using stable isotope mass spectrometry. J Biol (2006) 4.04
Derivation and validation of a practical risk score for prediction of mortality after open repair of ruptured abdominal aortic aneurysms in a US regional cohort and comparison to existing scoring systems. J Vasc Surg (2012) 2.78
The effect of postoperative myocardial ischemia on long-term survival after vascular surgery. J Vasc Surg (2013) 2.72
Statins are independently associated with reduced mortality in patients undergoing infrainguinal bypass graft surgery for critical limb ischemia. J Vasc Surg (2008) 2.55
Inhibition of vascular smooth muscle cell migration by cytochrome p450 epoxygenase-derived eicosanoids. Circ Res (2002) 2.53
Peripheral arterial interventions: trends in market share and outcomes by specialty, 1998-2005. J Vasc Surg (2009) 2.20
Optimal selection of asymptomatic patients for carotid endarterectomy based on predicted 5-year survival. J Vasc Surg (2013) 2.16
Elevated C-reactive protein levels are associated with postoperative events in patients undergoing lower extremity vein bypass surgery. J Vasc Surg (2006) 2.14
Factors associated with death 1 year after lower extremity bypass in Northern New England. J Vasc Surg (2009) 1.86
Disparity in outcomes of surgical revascularization for limb salvage: race and gender are synergistic determinants of vein graft failure and limb loss. Circulation (2008) 1.80
Carotid artery stenting has increased rates of postprocedure stroke, death, and resource utilization than does carotid endarterectomy in the United States, 2005. J Vasc Surg (2008) 1.78
Risk prediction of 30-day readmission after infrainguinal bypass for critical limb ischemia. J Vasc Surg (2013) 1.72
Outcomes and practice patterns in patients undergoing lower extremity bypass. J Vasc Surg (2012) 1.53
Subjective assessment of right ventricle enlargement from computed tomography pulmonary angiography images. Int J Cardiovasc Imaging (2011) 1.48
Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis. Am J Pathol (2010) 1.47
Risk stratification in critical limb ischemia: derivation and validation of a model to predict amputation-free survival using multicenter surgical outcomes data. J Vasc Surg (2008) 1.47
An analysis of carotid artery stenting procedures performed in New York and Florida (2005-2006): procedure indication, stroke rate, and mortality rate are equivalent for vascular surgeons and non-vascular surgeons. J Vasc Surg (2009) 1.44
Clinical consequence of bare metal stent and stent graft failure in femoropopliteal occlusive disease. J Vasc Surg (2013) 1.42
Inhibitor of apoptosis protein survivin regulates vascular injury. Nat Med (2002) 1.42
The Vascular Study Group of New England Cardiac Risk Index (VSG-CRI) predicts cardiac complications more accurately than the Revised Cardiac Risk Index in vascular surgery patients. J Vasc Surg (2010) 1.34
Early remodeling of lower extremity vein grafts: inflammation influences biomechanical adaptation. J Vasc Surg (2008) 1.21
Early biomechanical changes in lower extremity vein grafts--distinct temporal phases of remodeling and wall stiffness. J Vasc Surg (2006) 1.19
Validation of the Society for Vascular Surgery's objective performance goals for critical limb ischemia in everyday vascular surgery practice. J Vasc Surg (2011) 1.16
Mechanisms of premature vascular aging in children with Hutchinson-Gilford progeria syndrome. Hypertension (2011) 1.16
National trends in utilization and postprocedure outcomes for carotid artery revascularization 2005 to 2007. J Vasc Surg (2010) 1.15
Clinical results of carotid artery stenting compared with carotid endarterectomy. J Vasc Surg (2008) 1.15
Validation of the PIII CLI risk score for the prediction of amputation-free survival in patients undergoing infrainguinal autogenous vein bypass for critical limb ischemia. J Vasc Surg (2009) 1.14
Prior failed ipsilateral percutaneous endovascular intervention in patients with critical limb ischemia predicts poor outcome after lower extremity bypass. J Vasc Surg (2011) 1.13
D-series resolvin attenuates vascular smooth muscle cell activation and neointimal hyperplasia following vascular injury. FASEB J (2013) 1.12
Endovascular treatment of ruptured abdominal aortic aneurysms in the United States (2001-2006): a significant survival benefit over open repair is independently associated with increased institutional volume. J Vasc Surg (2009) 1.12
Matrix metalloproteinase-specific inhibition of Ca2+ entry mechanisms of vascular contraction. J Vasc Surg (2004) 1.09
Factors associated with amputation or graft occlusion one year after lower extremity bypass in northern New England. Ann Vasc Surg (2009) 1.09
Female gender and oral anticoagulants are associated with wound complications in lower extremity vein bypass: an analysis of 1404 operations for critical limb ischemia. J Vasc Surg (2007) 1.09
Failure to achieve clinical improvement despite graft patency in patients undergoing infrainguinal lower extremity bypass for critical limb ischemia. J Vasc Surg (2010) 1.08
Technical factors affecting autogenous vein graft failure: observations from a large multicenter trial. J Vasc Surg (2007) 1.07
Under-representation of women and ethnic minorities in vascular surgery randomized controlled trials. J Vasc Surg (2009) 1.05
Chemical mediators of inflammation and resolution in post-operative abdominal aortic aneurysm patients. Inflammation (2012) 1.04
odd skipped related1 reveals a novel role for endoderm in regulating kidney versus vascular cell fate. Development (2008) 1.04
Protamine reduces bleeding complications associated with carotid endarterectomy without increasing the risk of stroke. J Vasc Surg (2010) 1.04
Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts. J Vasc Surg (2004) 1.03
Prospective multicenter study of quality of life before and after lower extremity vein bypass in 1404 patients with critical limb ischemia. J Vasc Surg (2006) 1.03
Surgeon case volume, not institution case volume, is the primary determinant of in-hospital mortality after elective open abdominal aortic aneurysm repair. J Vasc Surg (2010) 1.03
Refinement of survival prediction in patients undergoing lower extremity bypass surgery: stratification by chronic kidney disease classification. J Vasc Surg (2007) 1.03
Outcomes of symptomatic abdominal aortic aneurysm repair. J Vasc Surg (2010) 1.02
Outcomes of upper arm arteriovenous fistulas for maintenance hemodialysis access. Arch Surg (2004) 1.01
Regulation of vein graft hyperplasia by survivin, an inhibitor of apoptosis protein. Arterioscler Thromb Vasc Biol (2005) 1.01
Inhibitory effect of mTOR activator MHY1485 on autophagy: suppression of lysosomal fusion. PLoS One (2012) 1.01
Comparative analysis of autogenous infrainguinal bypass grafts in African Americans and Caucasians: the association of race with graft function and limb salvage. J Vasc Surg (2005) 1.00
Early adaptation of human lower extremity vein grafts: wall stiffness changes accompany geometric remodeling. J Vasc Surg (2004) 0.99
Effect of lateral positioning on upper airway size and morphology in sedated children. Anesthesiology (2005) 0.99
A novel role of three dimensional graphene foam to prevent heater failure during boiling. Sci Rep (2013) 0.99
Comparison of carotid endarterectomy and stenting in real world practice using a regional quality improvement registry. J Vasc Surg (2012) 0.98
In vivo differentiation of two vessel wall layers in lower extremity peripheral vein bypass grafts: application of high-resolution inner-volume black blood 3D FSE. Magn Reson Med (2009) 0.96
Preoperative risk factors for carotid endarterectomy: defining the patient at high risk. J Vasc Surg (2003) 0.96
Surgical and endovascular revision of infrainguinal vein bypass grafts: analysis of midterm outcomes from the PREVENT III trial. J Vasc Surg (2007) 0.96
Predicting functional status following amputation after lower extremity bypass. Ann Vasc Surg (2012) 0.95
Lower extremity vein graft failure: a translational approach. Vasc Med (2008) 0.95
Infrainguinal vein bypass graft revision: factors affecting long-term outcome. J Vasc Surg (2004) 0.94
Inferior outcomes of autogenous infrainguinal bypass in Hispanics: an analysis of ethnicity, graft function, and limb salvage. J Vasc Surg (2009) 0.94
Survivin expression is up-regulated in vascular injury and identifies a distinct cellular phenotype. J Vasc Surg (2005) 0.94
Clinical practice. Acute limb ischemia. N Engl J Med (2012) 0.93
Modulation of age-related NF-kappaB activation by dietary zingerone via MAPK pathway. Exp Gerontol (2010) 0.93
Novel adipokines, high molecular weight adiponectin and resistin, are associated with outcomes following lower extremity revascularization with autogenous vein. J Vasc Surg (2010) 0.93
The N-glycoform of sRAGE is the key determinant for its therapeutic efficacy to attenuate injury-elicited arterial inflammation and neointimal growth. J Mol Med (Berl) (2013) 0.93
Self-assembled foam-like graphene networks formed through nucleate boiling. Sci Rep (2013) 0.93
PPARγ activation by baicalin suppresses NF-κB-mediated inflammation in aged rat kidney. Biogerontology (2011) 0.92
Variation in smoking cessation after vascular operations. J Vasc Surg (2013) 0.92
Clopidogrel is not associated with major bleeding complications during peripheral arterial surgery. J Vasc Surg (2011) 0.92
Upper arm arteriovenous fistula versus forearm looped arteriovenous graft for hemodialysis access: a comparative analysis. Ann Vasc Surg (2005) 0.91
2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol (2016) 0.91
Effects of fatty acids on endothelial cells: inflammation and monocyte adhesion. J Surg Res (2012) 0.90
2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol (2016) 0.90
Resource utilization in the treatment of critical limb ischemia: The effect of tissue loss, comorbidities, and graft-related events. J Vasc Surg (2006) 0.90
n-3 Polyunsaturated fatty acids supplementation in peripheral artery disease: the OMEGA-PAD trial. Vasc Med (2013) 0.89
In vivo human lower extremity saphenous vein bypass grafts manifest flow mediated vasodilation. J Vasc Surg (2009) 0.89
High-resolution peripheral vein bypass graft wall studies using high sampling efficiency inner volume 3D FSE. Magn Reson Med (2008) 0.89
Growing impact of restenosis on the surgical treatment of peripheral arterial disease. J Am Heart Assoc (2013) 0.89
C-reactive protein and vein graft disease: evidence for a direct effect on smooth muscle cell phenotype via modulation of PDGF receptor-beta. Am J Physiol Heart Circ Physiol (2008) 0.88
Setting high-impact clinical research priorities for the Society for Vascular Surgery. J Vasc Surg (2013) 0.88
Critical limb ischemia. Curr Treat Options Cardiovasc Med (2010) 0.88
Use of alternative methodologies for evaluation of composite end points in trials of therapies for critical limb ischemia. Am Heart J (2012) 0.88
Peripheral artery disease and risk of cardiovascular events in patients with coronary artery disease: insights from the Heart and Soul Study. Vasc Med (2013) 0.86
Outcome in patients at high risk after open surgical repair of abdominal aortic aneurysm. J Vasc Surg (2003) 0.86
Multi-contrast high spatial resolution black blood inner volume three-dimensional fast spin echo MR imaging in peripheral vein bypass grafts. Int J Cardiovasc Imaging (2010) 0.86
The effect of postoperative stroke and myocardial infarction on long-term survival after carotid revascularization. J Vasc Surg (2013) 0.86
Computed tomography and echocardiography in patients with acute pulmonary embolism: part 2: prognostic value. J Thorac Imaging (2014) 0.86
Effects of gravitational mechanical unloading in endothelial cells: association between caveolins, inflammation and adhesion molecules. Sci Rep (2013) 0.86
Suprarenal aortic cross-clamp position: a reappraisal of its effects on outcomes for open abdominal aortic aneurysm repair. J Vasc Surg (2009) 0.86
Atherosclerotic Peripheral Vascular Disease Symposium II: lower-extremity revascularization: state of the art. Circulation (2008) 0.86
The impact of patient age and aortic size on the results of aortobifemoral bypass grafting. J Vasc Surg (2003) 0.85